Zacks Investment Research upgraded shares of Imperva (NASDAQ:IMPV) from a hold rating to a strong-buy rating in a research note published on Friday. The firm currently has $53.00 price objective on the software maker’s stock.
According to Zacks, “Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company’s SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. “
IMPV has been the subject of a number of other research reports. BidaskClub downgraded Imperva from a hold rating to a sell rating in a report on Wednesday, December 27th. Morgan Stanley reiterated an underweight rating and issued a $39.00 price objective on shares of Imperva in a report on Thursday, November 9th. Stifel Nicolaus reiterated a hold rating and issued a $47.00 price objective (down previously from $50.00) on shares of Imperva in a report on Thursday, November 9th. Evercore ISI set a $56.00 price objective on Imperva and gave the company a buy rating in a report on Thursday, October 19th. Finally, Imperial Capital upped their price objective on Imperva from $50.00 to $55.00 and gave the company an outperform rating in a report on Friday, February 9th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of Buy and a consensus target price of $53.14.
Imperva (NASDAQ:IMPV) last released its quarterly earnings data on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.13. The business had revenue of $91.10 million during the quarter, compared to the consensus estimate of $91.11 million. Imperva had a negative return on equity of 3.37% and a net margin of 7.11%. The firm’s revenue was up 16.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.32 earnings per share. equities analysts expect that Imperva will post -0.17 earnings per share for the current fiscal year.
Large investors have recently bought and sold shares of the business. New York State Common Retirement Fund grew its stake in Imperva by 5.3% in the second quarter. New York State Common Retirement Fund now owns 35,800 shares of the software maker’s stock valued at $1,713,000 after acquiring an additional 1,793 shares during the period. Prudential Financial Inc. boosted its position in shares of Imperva by 80.7% during the third quarter. Prudential Financial Inc. now owns 54,174 shares of the software maker’s stock worth $2,351,000 after buying an additional 24,190 shares during the period. Wells Fargo & Company MN boosted its position in shares of Imperva by 11.9% during the third quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock worth $9,285,000 after buying an additional 22,741 shares during the period. American Century Companies Inc. acquired a new position in shares of Imperva during the third quarter worth about $6,832,000. Finally, Bank of New York Mellon Corp boosted its position in shares of Imperva by 10.8% during the third quarter. Bank of New York Mellon Corp now owns 150,752 shares of the software maker’s stock worth $6,542,000 after buying an additional 14,727 shares during the period. 95.91% of the stock is owned by hedge funds and other institutional investors.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.